What's Happening?
Dr. Patrick Soon-Shiong, founder of ImmunityBio, will be a featured speaker at the 'Cancer 2035: A Roadmap for the Future' summit in Washington, D.C. The event, co-hosted by the Milken Institute and the Richard Nixon Foundation, marks the 55th anniversary
of the National Cancer Act. It brings together leading figures in oncology and health policy to discuss strategies for reducing cancer mortality by 2035. Dr. Soon-Shiong will join other prominent speakers, including Nobel laureates and former NIH directors, to explore the role of scientific and technological advancements in cancer treatment.
Why It's Important?
The summit highlights the ongoing efforts to combat cancer through innovation and collaboration. Dr. Soon-Shiong's participation underscores ImmunityBio's commitment to advancing immunotherapy and cell therapy platforms. The event aims to foster dialogue among experts to drive progress in cancer research and treatment, potentially leading to breakthroughs that could significantly impact cancer mortality rates. The discussions will focus on leveraging current scientific capabilities to enhance cancer care and explore new frontiers in prevention and treatment.
What's Next?
The summit will feature discussions on the future of cancer treatment, including the development of clinical trial infrastructures and public-private partnerships. The outcomes of these discussions could influence future research directions and policy decisions, shaping the landscape of cancer treatment over the next decade. ImmunityBio's involvement in the summit may also lead to new collaborations and initiatives aimed at accelerating the development of innovative cancer therapies.
